Call for Papers

Please contact the symposium organizers with questions.

This symposium aims to bring together scientists engaged in interdisciplinary research focused on disease diagnostics and therapy. It leverages nanomaterials designed to respond to specific pathologic microenvironment, such as reactive oxygen species, pH, temperature, enzymatic activity, etc., or certain stimuli, such as light, magnetic fields, ultrasound, radiation, and microwaves. Nanomaterials, characterized by variations in sizes, shapes, chemical compositions, and surface chemistry, are increasingly pertinent for imaging and therapy. Bioresponsive nanomaterials, capable of reacting to specific stimuli and environments, offer heightened sensitivity, improved efficiency, and minimized side effects. The design and synthesis of materials for imaging and therapy, particularly for complex diseases like cancer, pose significant research challenges. Nevertheless, multifunctional nanomaterials hold the potential to address these challenges. Additionally, immunotherapy has shown exceptional promise in cancer therapy. Bioresponsive nanomaterials could augment the effectiveness of immunotherapy and broaden its application to a wider range of diseases. Furthermore, the integration of artificial intelligence (AI) or machine learning (ML) technology has the potential to expedite the development of emerging bioresponsive nanomaterials for disease theranostics.

This symposium has been designed to provide an opportunity to discuss the most recent advances in bioresponsive nanomaterials, including current challenges and future directions. The topics will include the synthesis, characterization, and application of emerging and new nanomaterials in imaging, therapy, and biomedical engineering. Additionally, discussions will encompass immunotherapy and the design of nanomaterials assisted by artificial intelligence.

Topics will include:

• Responsive Nanomaterials for Targeted Drug Delivery and Therapy
• Multifunctional Nanocarriers for Imaging, Diagnostics, and Therapy
• Smart Nanomaterials for Real-Time Biosensing and Therapeutic Interventions
• Emerging Nanotechnologies in Cancer Immunotherapy
• Magnetic Nanomaterials in Imaging and Hyperthermia Treatment
• Responsive Biomaterials and Tissue Engineering
• Emerging Nanotechnologies for Metabolic Therapy
• AI-Driven Nanomaterial Design for Precision Medicine
• Case Studies: Nanomaterial Applications in Imaging and Therapy

Invited Speakers (tentative):

• Stacy Copp (University of California, Irvine, USA)
• Tram Dang (Nanyang Technological University, Singapore)
• Geme-Louise Davies (University of Birmingham, United Kingdom)
• Clare Hoskins (University of Strathclyde, United Kingdom)
• Taeghwan Hyeon (Seoul National University, Republic of Korea)
• Gavin Jell (University College London, United Kingdom)
• Nazila Kamaly (Imperial College London, United Kingdom)
• Jessica Larsen (Clemson University, USA)
• Fangyuan Li (Shanghai Jiaotong University School of Medicine, China)
• Fuyou Li (Fudan University, China)
• Yuanpei Li (University of California, Davis, USA)
• Alessandro Poma (University College London, United Kingdom)
• Carlos Rinaldi-Ramos (University of Florida, USA)
• Zeev Rosenzweig (University of Maryland, Baltimore County, USA)
• Graeme Stasiuk (King's College London, United Kingdom)
• Xiaodi Su (National University of Singapore, Singapore)
• Nguyen T. K. Thanh (University College London, United Kingdom)
• Jun Wang (South China University of Technology, China)
• Gareth Williams (University College London, United Kingdom)
• Qian Yin (Stanford University, USA)
• Lanry Yung (National University of Singapore, Singapore)

Symposium Organizers